Very Long Chain Acyl Coa Dehydrogenase Deficiency
Oncology·MeSH: Beta ketothiolase deficiency
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Very Long Chain Acyl Coa Dehydrogenase Deficiency?
There are 1 clinical trial targeting Very Long Chain Acyl Coa Dehydrogenase Deficiency tracked by BioSniper.
What is the prevalence of Very Long Chain Acyl Coa Dehydrogenase Deficiency?
The estimated prevalence of Very Long Chain Acyl Coa Dehydrogenase Deficiency is approximately 5.0 per 100,000 population.
Deep-dive into Very Long Chain Acyl Coa Dehydrogenase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis